Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Localised anal squamous cell carcinoma (stage I to III), drawn from the whole corpus: 1 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Radiotherapy dose for early and for locally advanced tumours is still being settled in PLATO.
About a quarter of patients with locally advanced disease relapse and need major surgery.
Nothing recorded yet.
Nothing recorded yet.
Also on OnCo: Atlas of advanced disease · How cancer spreads: the metastasis stages.
Late bowel, sexual and bladder effects of pelvic chemoradiotherapy are common and under-measured.
Whether adding a PD-1 antibody to chemoradiotherapy improves cure is untested outside EA2165.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 8 changes by month →When this page itself was last checked or edited.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
Complete response about 90% with either mitomycin or cisplatin; no benefit from maintenance chemotherapy.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.